Annovis Bio Cash from Financing (TTM) Trends

Annovis Bio Inc (ANVS)

9.85 +0.86 (+9.57%) USD | NYSE | Apr 18, 16:00

10.16 +0.31 (+3.15%) Pre-Market: 08:45

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	17.34M
September 30, 2023	8.580M
June 30, 2023	8.580M
March 31, 2023	0.0074M
December 31, 2022	0.0046M
September 30, 2022	0.0046M
June 30, 2022	-0.0208M
March 31, 2022	46.75M
December 31, 2021	46.74M
September 30, 2021	46.74M
June 30, 2021	46.77M

Date	Value
March 31, 2021	-0.0424M
December 31, 2020	12.04M
September 30, 2020	12.04M
June 30, 2020	12.04M
March 31, 2020	12.00M
December 31, 2019	0.4431M
September 30, 2019	0.445M
June 30, 2019	0.4486M
March 31, 2019	0.5328M
December 31, 2018	0.2464M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.0424M

Minimum

Mar 2021

46.77M

Maximum

Jun 2021

14.26M

Average

8.580M

Median

Jun 2023

Cash from Financing (TTM) Benchmarks